The Consumer & Prescriber Grant Program (also going by other names, including Attorney General Prescriber Grant Program) was a grant program established with fines paid by Pfizer in the Franklin v. Parke-Davis trial for False Claims Act violations relating to off-label use of gabapentin.[1][2]
Grant recipients
There were 24 original grant recipients.
External links
- Official website archival copy from March 2011. The website existed from 2008-2011.
References
- Lainie Rutkow, Stephen Teret. The Potential for State Attorneys General to Promote the Public's Health: Theory, Evidence, and Practice Robert Wood Johnson Foundation Public Health Law Research Program, via FOLIO, October 2010^
- DW Price, MA Raebel, DA Conner, LA Wright. Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs. The Permanente Journal, 2008^
- Attorney Generals' Prescriber and Consumer Education Grant